Overview
- Sweet disclosed on Dec. 9 that a Nov. 17 biopsy of a right‑thyroid nodule was malignant, confirming papillary thyroid cancer.
- A CT scan and ultrasound are set for Dec. 15, followed by a Dec. 22 meeting with his doctor and surgeon to determine next steps.
- Stryper will begin recording a new album on Dec. 28 as scheduled, with Sweet planning surgery to remove the right thyroid and nodule after tracking.
- Papillary thyroid cancer is the most common thyroid cancer and is typically slow‑growing with favorable outcomes when treated early.
- Sweet acknowledged recent vocal difficulties, apologized to fans, and said he expects to recover and return to touring in 2026; he previously had the left half of his thyroid removed in December 2023.